Capital expenditure · 2016–2025
Krystal Biotech capital expenditure
$12.0M+182.0% · FY2025
Krystal Biotech (KRYS) reported $12.0M in capital expenditure for fiscal 2025, +182.0% year on year.
| Fiscal year | Capital expenditure | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $12.0M | +182.0% | Open → |
| FY20242024-12-31 | $4.2M | −64.1% | Open → |
| FY20232023-12-31 | $11.8M | −77.7% | Open → |
| FY20222022-12-31 | $53.0M | −22.5% | Open → |
| FY20212021-12-31 | $68.3M | +360.4% | Open → |
| FY20202020-12-31 | $14.8M | +132.0% | Open → |
| FY20192019-12-31 | $6.4M | +186.4% | Open → |
| FY20182018-12-31 | $2.2M | +963.8% | Open → |
| FY20172017-12-31 | $210,000 | +1,300.0% | Open → |
| FY20162016-12-31 | $15,000 | — | Open → |
Capital expenditure — Capital expenditure is the cash the company spent during the year on property, plant and equipment — factories, stores, servers, vehicles. It appears in the investing section of the cash-flow statement as an outflow and is shown here as a positive amount. Operating cash flow minus this figure is free cash flow.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2016–2025 compound annual growth +110.1%
Capital expenditure at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Krystal Biotech capital expenditure |url=https://companiesranked.com/en/company/krystal-biotech/capital-expenditure |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Krystal Biotech capital expenditure. CompaniesRanked. https://companiesranked.com/en/company/krystal-biotech/capital-expenditureBibTeX
@misc{companiesranked-en-company-krystal-biotech-capital-expenditure-2026,
author = {{CompaniesRanked}},
title = {{Krystal Biotech capital expenditure}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/krystal-biotech/capital-expenditure}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001711279-26-000016 · February 17, 2026
{{cite web |title=Krystal Biotech capital expenditure — 10-K (0001711279-26-000016) |url=https://www.sec.gov/Archives/edgar/data/1711279/000171127926000016/krys-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-17}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.